Rectum neuroendocrine neoplasm

disease
On this page

Also known as NET of the rectumneuroendocrine neoplasm of rectumneuroendocrine neoplasm of the rectumneuroendocrine tumor of rectumneuroendocrine tumour of rectumrectal NETrectal neuroendocrine neoplasmrectal neuroendocrine tumorrectum NETrectum neuroendocrine tumorrectum neuroendocrine tumor, well differentiated, low or intermediate graderectum neuroendocrine tumour

Summary

Rectum neuroendocrine neoplasm (MONDO:0003646) is a cancer and 7 clinical trials. A subtype of intestinal neuroendocrine neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Phenotypes (HPO): 25
  • Clinical trials: 7

Clinical features

Signs & symptoms

Clinical features (HPO)

25 HPO clinical features (Orphanet curated; top 25 by frequency):

HPO IDTermFrequency
HP:0100570Carcinoid tumorObligate (100%)
HP:0001824Weight lossFrequent (30-79%)
HP:0002019ConstipationFrequent (30-79%)
HP:0002027Abdominal painFrequent (30-79%)
HP:0002039AnorexiaFrequent (30-79%)
HP:0002573HematocheziaFrequent (30-79%)
HP:0012702TenesmusFrequent (30-79%)
HP:0025085Bloody diarrheaFrequent (30-79%)
HP:0030144Hypoactive bowel soundsFrequent (30-79%)
HP:0030446Atypical pulmonary carcinoid tumorFrequent (30-79%)
HP:0002240HepatomegalyOccasional (5-29%)
HP:0002249MelenaOccasional (5-29%)
HP:0002730Chronic noninfectious lymphadenopathyOccasional (5-29%)
HP:0002910Elevated circulating hepatic transaminase concentrationOccasional (5-29%)
HP:4000007BronchoconstrictionVery rare (<1-4%)
HP:0001708Right ventricular failureVery rare (<1-4%)
HP:0001962PalpitationsVery rare (<1-4%)
HP:0002615HypotensionVery rare (<1-4%)
HP:0003144Increased serum serotoninVery rare (<1-4%)
HP:0004385Protracted diarrheaVery rare (<1-4%)
HP:0005180Tricuspid regurgitationVery rare (<1-4%)
HP:0007380Facial telangiectasiaVery rare (<1-4%)
HP:0012701Bowel urgencyVery rare (<1-4%)
HP:0030145Lack of bowel soundsVery rare (<1-4%)
HP:0031566Abnormal pulmonary valve cusp morphologyVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical namerectum neuroendocrine neoplasm
Mondo IDMONDO:0003646
Orphanet100081
DOIDDOID:5777
ICD-111619951900
NCITC5698
UMLSC1335686
MedGen277576
GARD0019756
Anatomy (UBERON)UBERON:0001052
Is cancer (heuristic)yes

Also known as: NET of the rectum · neuroendocrine neoplasm of rectum · neuroendocrine neoplasm of the rectum · neuroendocrine tumor of rectum · neuroendocrine tumour of rectum · rectal NET · rectal neuroendocrine neoplasm · rectal neuroendocrine tumor · rectum NET · rectum neuroendocrine neoplasm · rectum neuroendocrine tumor · rectum neuroendocrine tumor, well differentiated, low or intermediate grade · rectum neuroendocrine tumour

Data availability: 1 cell line.

Disease family

This is a subtype of intestinal neuroendocrine neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderintestinal disorderintestinal neoplasmintestinal neuroendocrine neoplasmrectum neuroendocrine neoplasm

Related subtypes (3): colon neuroendocrine neoplasm, small intestine neuroendocrine neoplasm, intestinal neuroendocrine tumor G1

Subtypes (2): anal canal neuroendocrine neoplasm, rectal neuroendocrine tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 7.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified7

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05429216Not specifiedNOT_YET_RECRUITINGEndoscopic Resection for Small Rectal Neuroendocrine Tumors
NCT06279299Not specifiedRECRUITINGLateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision
NCT06901856Not specifiedNOT_YET_RECRUITINGEndoscopic Resection for Small Rectal Neuroendocrine Tumors
NCT07373015Not specifiedNOT_YET_RECRUITINGModified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
NCT07410767Not specifiedNOT_YET_RECRUITINGAdvanced Endoscopic Resections for Rectal Neoplasms
NCT07612748Not specifiedNOT_YET_RECRUITINGTwo Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms
NCT03982264Not specifiedUNKNOWNEndoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.